Abstract | OBJECTIVE: APPROACH AND RESULTS: Native LDL ( LDL(+)) and LDL(-) separated by anion-exchange chromatography were added to THP1-CD14 monocytes in the presence or absence of SDX for 24 h. A panel of 9 MMPs and 4 TIMPs was analyzed in cell supernatants with multiplex immunoassays. The gelatinolytic activity of MMP-9 was assessed by gelatin zymography. LDL(-) stimulated the release of MMP-9 (13-fold) and TIMP-1 (4-fold) in THP1-CD14 monocytes, as well as the gelatinolytic activity of MMP-9. Co-incubation of monocytes with LDL(-) and SDX for 24 h significantly reduced both the release of MMP-9 and TIMP-1 and gelatinase activity. In THP1 cells not expressing CD14, no effect of LDL(-) on MMP-9 or TIMP-1 release was observed. The uptake of DiI-labeled LDL(-) was higher than that of DiI- LDL(+) in THP1-CD14 but not in THP1 cells. This increase was inhibited by SDX. Experiments in microtiter wells coated with SDX demonstrated a specific interaction of LDL(-) with SDX. CONCLUSIONS:
LDL(-) induced the release of MMP-9 and TIMP-1 in monocytes through CD14. SDX affects the ability of LDL(-) to promote TIMP-1 and MMP-9 release by its interaction with LDL(-).
|
Authors | Daniela Ligi, Sonia Benitez, Lidia Croce, Andrea Rivas-Urbina, Núria Puig, Jordi Ordóñez-Llanos, Ferdinando Mannello, Jose Luis Sanchez-Quesada |
Journal | Biochimica et biophysica acta. Molecular basis of disease
(Biochim Biophys Acta Mol Basis Dis)
Vol. 1864
Issue 12
Pg. 3559-3567
(12 2018)
ISSN: 1879-260X [Electronic] Netherlands |
PMID | 30254012
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Glycosaminoglycans
- Hypolipidemic Agents
- Lipopolysaccharide Receptors
- Lipoproteins, LDL
- Tissue Inhibitor of Metalloproteinase-1
- glucuronyl glucosamine glycan sulfate
- Matrix Metalloproteinase 9
|
Topics |
- Anti-Inflammatory Agents
(pharmacology)
- Cell Line
- Glycosaminoglycans
(pharmacology)
- Humans
- Hypolipidemic Agents
(pharmacology)
- Lipopolysaccharide Receptors
(immunology)
- Lipoproteins, LDL
(chemistry, immunology)
- Matrix Metalloproteinase 9
(immunology)
- Monocytes
(drug effects, immunology)
- Static Electricity
- Tissue Inhibitor of Metalloproteinase-1
(immunology)
|